focus
Previous article:
Affirmative action in medical school literally saved lives
Next article: Eli Lilly reports tirzepatide MASH success during Q4 earnings
Next article: Eli Lilly reports tirzepatide MASH success during Q4 earnings
knowledge
leisure time
-
Readout Newsletter: Amylyx, Aurinia, and IQVIA
2025-09-30 17:22 -
The Karikó problem: Lessons for funding basic research
2025-09-30 17:08 -
CDC picks Alphabet's Verily for wasterwater surveillance contract
2025-09-30 17:02 -
Readout Newsletter: Replicate, Biogen's Leqembi, and Humira
2025-09-30 16:15 -
Readout Newsletter: Replicate, Biogen's Leqembi, and Humira
2025-09-30 15:51 -
Juul documents reveal insider tactics on political lobbying
2025-09-30 15:13